GE HealthCare officer reports equity holdings
GE HealthCare Technologies Inc. executive Catherine Estrampes, Chief Commercial & Growth Officer, reports beneficial ownership of 24,081 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
GE HealthCare Technologies Inc. executive Catherine Estrampes, Chief Commercial & Growth Officer, reports beneficial ownership of 24,081 shares of common stock. This includes 14,374 shares plus restricted stock units that may settle into additional shares as they vest.
She also holds multiple employee stock options on GE HealthCare common stock. These options cover underlying share amounts such as 16,398 shares at an exercise price of $80.16 expiring on March 2, 2036, and 9,923 shares at $86.45 expiring on March 3, 2035, along with several other grants with different prices and expirations.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
Estrampes Catherine
Role
Chief Commer. & Growth Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock, par value $0.01 per share | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 70,703 contracts (Direct);
Common Stock, par value $0.01 per share — 24,081 shares (Direct)
Footnotes (8)
- F1. Consists of (i) 14,374 shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock; (ii) 3,470 restricted stock units with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028; and (iii) 6,237 restricted stock units with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
- F2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
- F3. Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the distribution of shares of GE HealthCare common stock by GE to holders of GE common stock on a pro rata basis, 100% of which is currently exercisable.
- F4. Award of an employee stock option with respect to GE HealthCare common stock, granted on February 1, 2023, of which 100% is currently exercisable.
- F5. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2023, of which 100% is currently exercisable.
- F6. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2024, of which 100% is currently exercisable.
- F7. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028.
- F8. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.
Key Figures
Common shares owned: 24,081 shares
Direct common shares: 14,374 shares
RSUs grant 2025: 3,470 units
+5 more
8 metrics
Common shares owned
24,081 shares
Total beneficial ownership of GE HealthCare common stock
Direct common shares
14,374 shares
Portion of total common stock held directly
RSUs grant 2025
3,470 units
Restricted stock units granted March 3, 2025
RSUs grant 2026
6,237 units
Restricted stock units granted March 2, 2026
Option position A
16,398 shares at $80.16
Employee stock option, expiration March 2, 2036
Option position B
9,923 shares at $86.45
Employee stock option, expiration March 3, 2035
Option position C
8,052 shares at $92.72
Employee stock option, expiration March 1, 2034
Option position D
14,109 shares at $70.01
Employee stock option, expiration February 1, 2033
Key Terms
restricted stock units, employee stock option, equity incentive awards, beneficial ownership, +1 more
5 terms
restricted stock units financial
"3,470 restricted stock units with respect to GE HealthCare common stock, granted on March 3, 2025"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
employee stock option financial
"Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
equity incentive awards financial
"conversion of certain equity incentive awards previously granted by General Electric Company"
Equity incentive awards are company grants that pay employees or directors with a stake in the business—typically stock, stock options, or restricted shares—rather than only cash. They matter to investors because they align employees’ interests with shareholders (like giving team members slices of the same pie to encourage growth) but can also increase the total number of shares outstanding, which can reduce each existing shareholder’s percentage ownership and impact reported profits.
beneficial ownership financial
"reports beneficial ownership of 24,081 shares of GE HealthCare common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
exercise price financial
"exercisePrice: "80.1600" and other listed exercise prices for employee stock options"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What restricted stock units does GEHC officer Catherine Estrampes hold?
She holds 3,470 restricted stock units granted on March 3, 2025 and 6,237 restricted stock units granted on March 2, 2026. Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement, subject to vesting.
What stock options are reported for Catherine Estrampes in GEHC Form 3?
The filing lists several employee stock options on GE HealthCare common stock. Examples include options over 16,398 underlying shares at an exercise price of $80.16 expiring March 2, 2036, and 9,923 underlying shares at $86.45 expiring March 3, 2035.
When do Catherine Estrampes’ GEHC restricted stock units vest?
For the 3,470 restricted stock units granted March 3, 2025, vesting is scheduled 33% on September 3, 2026, 33% on September 3, 2027, and 34% on September 3, 2028. The 6,237 units granted March 2, 2026 vest on similar yearly September dates.
Are Catherine Estrampes’ GEHC employee stock options currently exercisable?
Some options are 100% currently exercisable, while others become exercisable over time. Footnotes state certain grants, including awards converted from General Electric Company equity incentives, are fully exercisable, and later grants begin vesting on specified September dates between 2026 and 2029.
AI-generated analysis. How Rhea-AI works. Not financial advice.
